Kliničke studije za Мигрена u državi Тенеси
7 studija za Мигрена traži učesnike na lokacijama u državi Тенеси.
Gradovi u državi Тенеси
Zvanični tekst studije (na engleskom)
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Vanderbilt Medical Center, Nashville
Тражи се учесникФаза 4
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06972056Study of EVO756 in Adults With Migraine
- Campbell Clinical Research, Franklin
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 13. 11. 2026. · NCT07616128A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- WR-ClinSearch, LLC, Chattanooga
- Access Clinical Trials, Inc, Nashville
- Clinical Research Associates, Inc., Nashville
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT07645924A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Access Clinical Trials Inc /ID# 270280, Nashville
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 9. 10. 2026. · NCT06810505Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- CNS Healthcare, Memphis
- Clinical Research Associates, Inc., Nashville
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 9. 10. 2026. · NCT07646613Responding With Evidence and Access for Childhood Headaches
- University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
Тражи се учесник
Узраст од 10 до 17 · Оба пола · Ажурирано 21. 9. 2026. · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Access Clinical Trials, Inc. /ID# 228002, Nashville
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 9. 2026. · NCT05125302Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.